Punjab Suspends Glycosting Injection Supply

Punjab's health authorities have ordered an immediate halt to the release, distribution, and supply of a batch of Glycosting injection after reports of a suspected adverse drug reaction.

Key points

• Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
• The Directorate of Drug Control, Punjab, issued the medicine stoppage alert under Alert No.
• The Provincial Quality Control Board has directed that the medicine be halted as a precaution while further investigation and regulatory action are carried out.
• Add as a preferredSource on Google Follow on Google News Join WhatsApp.
• It contains glycopyrrolate 0.5mg and neostigmine methylsulfate 2.5mg.

Meanwhile, the Directorate of Drug Control, Punjab, issued the medicine stoppage alert under Alert No. 125/2026.

Meanwhile, the affected product is Glycosting 1ml injection. It contains glycopyrrolate 0.5mg and neostigmine methylsulfate 2.5mg. The alert identifies the affected batch as BBG11, with an expiry date of January 2028. Study Finds Ozempic May Cut Severe Asthma Attacks.

Authorities remarked the product was noted to have caused suspected adverse drug reactions, including severe bradycardia, or an abnormally slow heart rate, at multiple healthcare facilities throughout Punjab.

Notably, the Provincial Quality Control Board has directed that the medicine be halted as a precaution while further investigation and regulatory action are carried out.

Manufacturers and market authorization holders have been informed to immediately stop the release, distribution and supply of the affected batch and submit relevant manufacturing, quality-control, distribution, complaint and pharmacovigilance records.

Pharmacies, wholesalers, distributors and healthcare facilities have additionally been instructed to stop administering, dispensing, selling, supplying or otherwise distributing the batch and quarantine any remaining stock. Study Reports Major Trial Success in Lung Cancer.

Healthcare facilities have been advised to report inventory and consumption records to the relevant drug inspector.

Patients and consumers have additionally been advised not to apply or receive the affected batch as a precaution. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover.

Taken together, the developments around punjab Suspends Glycosting Injection Supply point to a situation that is still moving, and the coming days should bring more clarity.